Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

1 2 3 4
zadetkov: 37
1.
  • Time from diagnosis to inst... Time from diagnosis to institutionalization and death in people with dementia
    Joling, Karlijn J.; Janssen, Olin; Francke, Anneke L. ... Alzheimer's & dementia, April 2020, Letnik: 16, Številka: 4
    Journal Article
    Recenzirano
    Odprti dostop

    Introduction Reliable estimates of time from diagnosis until institutionalization and death in people with dementia from routine nationally representative databases are lacking. Methods We selected ...
Celotno besedilo
Dostopno za: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK

PDF
2.
  • Immunogenicity of the 13-Va... Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
    Haggenburg, Sabine; Garcia Garrido, Hannah M; Kant, Iris M J ... Vaccines (Basel), 07/2023, Letnik: 11, Številka: 7
    Journal Article
    Recenzirano
    Odprti dostop

    Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
3.
  • Association between sedenta... Association between sedentary time and cognitive function: A focus on different domains of sedentary behavior
    Wanders, Lisa; Bakker, Esmée A.; van Hout, Hein P.J. ... Preventive medicine, December 2021, 2021-12-00, 20211201, Letnik: 153
    Journal Article
    Recenzirano
    Odprti dostop

    Studies which examined the association between sedentary behavior (SB) and cognitive function have presented equivocal findings. Mentally active/inactive sedentary domains may relate differently to ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
4.
  • Everyday Functioning in a C... Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report
    Verrijp, Merike; Dubbelman, Mark A; Visser, Leonie N C ... Frontiers in aging neuroscience, 01/2022, Letnik: 13
    Journal Article
    Recenzirano
    Odprti dostop

    Impaired awareness in dementia caused by Alzheimer's disease and related disorders made study partner-report the preferred method of measuring interference in "instrumental activities of daily ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK, VSZLJ

PDF
5.
  • Diagnosis, treatment and su... Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group
    Raa, Doreen G. Te; van der Straten, Lina; van Gelder, Michel ... Leukemia & lymphoma, 08/2022, Letnik: 63, Številka: 10
    Journal Article
    Recenzirano
    Odprti dostop

    Management of patients with chronic lymphocytic leukemia (CLL) is changing due to considerable advances in the therapeutic armamentarium, and new therapies will possibly continue to emerge in the ...
Celotno besedilo
Dostopno za: DOBA, IJS, IZUM, KILJ, NUK, PILJ, PNG, SAZU, UILJ, UKNU, UL, UM, UPUK
6.
  • First-line venetoclax combi... First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
    Fürstenau, Moritz; Kater, Arnon P; Robrecht, Sandra ... The lancet oncology, June 2024, 2024-Jun, 2024-06-00, 20240601, Letnik: 25, Številka: 6
    Journal Article
    Recenzirano
    Odprti dostop

    In the primary analysis report of the GAIA/CLL13 trial, we found that venetoclax–obinutuzumab and venetoclax–obinutuzumab–ibrutinib improved undetectable measurable residual disease (MRD) rates and ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP
7.
  • Fixed-duration venetoclax p... Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
    van der Straten, Lina; Stege, Claudia A. M.; Kersting, Sabina ... Blood, 09/2023, Letnik: 142, Številka: 13
    Journal Article
    Recenzirano
    Odprti dostop

    •Geriatric assessments can aid in identifying patients with less physical resilience who are at increased risk of grade ≥3 adverse events.•Fixed-duration Ven-O improves HRQoL in patients with CLL ...
Celotno besedilo
Dostopno za: IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZRSKP
8.
  • The Polycomb group protein ... The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
    Visser, Hein P. J.; Gunster, Marco J.; Kluin‐Nelemans, Hanneke C. ... British journal of haematology, March 2001, Letnik: 112, Številka: 4
    Journal Article
    Recenzirano

    Polycomb group (PcG) proteins are involved in the stable transmittance of the repressive state of their gene targets throughout the cell cycle. Mis‐expression of PcG proteins can lead to ...
Celotno besedilo
Dostopno za: BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK

PDF
9.
  • First-Line Treatment of Wal... First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline
    Amaador, Karima; Kersten, Marie José; Visser, Hein P. J. ... Hemato, 12/2022, Letnik: 3, Številka: 4
    Journal Article
    Recenzirano
    Odprti dostop

    Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
10.
  • Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
    Kersting, Sabina; Dubois, Julie; Nasserinejad, Kazem ... The Lancet. Haematology 9, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Fixed-duration 12 cycles of venetoclax plus obinutuzumab is established as first-line treatment for patients with chronic lymphocytic leukaemia. We aimed to determine the activity and safety of 12 ...
Celotno besedilo
Dostopno za: OILJ
1 2 3 4
zadetkov: 37

Nalaganje filtrov